KR100520936B1 - 항진균제 및 중합체로 코팅된 코어를 갖는 펠릿제 - Google Patents
항진균제 및 중합체로 코팅된 코어를 갖는 펠릿제 Download PDFInfo
- Publication number
- KR100520936B1 KR100520936B1 KR10-1999-7003848A KR19997003848A KR100520936B1 KR 100520936 B1 KR100520936 B1 KR 100520936B1 KR 19997003848 A KR19997003848 A KR 19997003848A KR 100520936 B1 KR100520936 B1 KR 100520936B1
- Authority
- KR
- South Korea
- Prior art keywords
- coating
- pellets
- itraconazole
- polymer
- pellet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Abstract
Description
시간(분) | 유효 투여량의 계산된 농도(w/w) | ||||||
시료 1 | 시료 2 | 시료 2 | 시료 3 | 시료 5 | 시료 6 | 평균 | |
0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
5 | 13.23 | 9.95 | 11.41 | 10.87 | 10.90 | 12.68 | 11.51 |
15 | 62.55 | 57.38 | 71.55 | 62.37 | 55.44 | 64.62 | 62.32 |
30 | 104.13 | 95.36 | 106.20 | 100.13 | 106.52 | 98.28 | 101.77 |
45 | 108.27 | 99.54 | 108.59 | 101.25 | 108.99 | 101.43 | 104.68 |
60 | 108.18 | 99.09 | 108.36 | 101.34 | 108.45 | 101.97 | 104.57 |
Claims (10)
- 코어가 250 - 355 ㎛ (45 - 60 메쉬)의 직경을 가짐을 특징으로 하는,a) 중심의, 원형 또는 구형의 코어,b) 수용성 중합체 및 이트라코나졸의 코팅 필름 및c) 밀봉-코팅 중합체층을 포함하는 펠릿.
- 제1항에 있어서, 펠릿의 총중량을 기준으로a) 코어 재료 10 내지 25 중량%,b) 수용성 중합체 39 내지 60 중량%,c) 이트라코나졸 26 내지 40 중량% 및d) 밀봉-코팅 중합체 4 내지 7 중량%를 포함하는 펠릿.
- 제2항에 있어서, 상기 코어 재료가 250 - 355 ㎛ (45 - 60 메쉬) 당 구이고, 수용성 고분자가 히드록시프로필 메틸셀룰로오스인 펠릿.
- 제3항에 있어서, 이트라코나졸:수용성 고분자의 중량 대 중량비가 1:1 내지 1:2인 펠릿.
- 제2항에 있어서, 밀봉 코팅 중합체가 폴리에틸렌 글리콜인 펠릿.
- 제3항에 있어서,a) 16.5 내지 19중량%의 당코어;b) 43 내지 48중량%의 히드록시프로필 메틸셀룰로오스 2910 5 mPa.s;c) 29 내지 33중량%의 이트라코나졸; 및d) 5 내지 6중량%의 폴리에틸렌 글리콜 20000을 포함하는 펠릿.
- 항진균 유효량의 제1항 내지 제6항 중 어느 한 항에 청구된 펠릿을 포함하는 제약학상 투여형.
- 제7항에 있어서, 상기 투여형이 경질-젤라틴 캡슐인 투여형.
- a) 250 내지 355 ㎛ (45 - 60 메쉬) 당 구를 이트라코나졸의 용액 및 염화 메틸렌 및 에탄올로 이루어진 유기 용매 중의 수용성 고분자의 용액으로 부르스터(Wurster)(저면 분무) 삽입구가 장착된 유동상 과립화기에서 분무시킴으로써 코팅시키고,b) 얻어진 코팅 코어를 건조시키고;c) 건조된 코어를 염화 메틸렌 및 에탄올로 이루어진 유기 용매 중의 밀봉-코팅 중합체의 용액으로 부루스터(저면 분무) 삽입구가 장착된 유동상 과립화기에서 분무시킴으로써 밀봉-코팅시킴을 특징으로 하는,제1항 내지 제6항 중 어느 한 항에 따른 펠릿의 제조 방법.
- 제9항에 따른 공정에 의해 얻어진 약물-코팅된 펠릿.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97200914 | 1997-03-26 | ||
EP97200914.6 | 1997-03-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000052971A KR20000052971A (ko) | 2000-08-25 |
KR100520936B1 true KR100520936B1 (ko) | 2005-10-17 |
Family
ID=8228147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-1999-7003848A KR100520936B1 (ko) | 1997-03-26 | 1998-03-18 | 항진균제 및 중합체로 코팅된 코어를 갖는 펠릿제 |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0969821B1 (ko) |
JP (1) | JP3608800B2 (ko) |
KR (1) | KR100520936B1 (ko) |
CN (1) | CN1206984C (ko) |
AP (1) | AP1227A (ko) |
AT (1) | ATE241969T1 (ko) |
AU (1) | AU734248B2 (ko) |
BG (1) | BG64434B1 (ko) |
BR (1) | BR9806174A (ko) |
CA (1) | CA2269501C (ko) |
CY (1) | CY2384B1 (ko) |
CZ (1) | CZ295502B6 (ko) |
DE (1) | DE69815316T2 (ko) |
DK (1) | DK0969821T3 (ko) |
EE (1) | EE03904B1 (ko) |
ES (1) | ES2201485T3 (ko) |
HK (1) | HK1022840A1 (ko) |
HU (1) | HU224217B1 (ko) |
ID (1) | ID21477A (ko) |
IL (1) | IL129575A (ko) |
NO (1) | NO325102B1 (ko) |
NZ (1) | NZ335364A (ko) |
OA (1) | OA11162A (ko) |
PL (1) | PL190566B1 (ko) |
PT (1) | PT969821E (ko) |
RU (1) | RU2218153C2 (ko) |
SI (1) | SI0969821T1 (ko) |
SK (1) | SK284813B6 (ko) |
TR (1) | TR199900990T2 (ko) |
UA (1) | UA60318C2 (ko) |
WO (1) | WO1998042318A1 (ko) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200002217T2 (tr) | 1998-07-17 | 2001-02-21 | Janssen Pharmaceutica N.V. | Bir mantar ilacı ve bir polimer ile kaplanmış bir çekirdeğe sahip taneler. |
ES2157731B1 (es) * | 1998-07-21 | 2002-05-01 | Liconsa Liberacion Controlada | Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion. |
JP2003531099A (ja) | 1999-03-24 | 2003-10-21 | エフ エム シー コーポレーション | 改良された水溶解度をもつ医薬製剤 |
KR100432949B1 (ko) * | 2000-06-13 | 2004-05-31 | 코오롱제약주식회사 | 생체이용율이 향상된 이트라코나졸의 분립체 조성물과이를 이용한 이트라코나졸 제제 및 그 제조방법 |
US6663897B2 (en) * | 2001-02-06 | 2003-12-16 | Dsm Ip Assets B.V. | Oral itraconazole formulations and methods of making the same |
ES2275866T3 (es) | 2001-02-14 | 2007-06-16 | Tibotec Pharmaceuticals Ltd. | 2-(aminosustituido)-benzotiazol-sulfonamidas de amplio esprecto inhibidoras de la proteasa de vih. |
PL367084A1 (en) | 2001-04-09 | 2005-02-21 | Tibotec Pharmaceuticals Ltd. | Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors |
CN100549007C (zh) | 2001-05-11 | 2009-10-14 | 泰博特克药品有限公司 | 广谱2-氨基-苯并唑磺酰胺hiv蛋白酶抑制剂 |
WO2002100407A1 (en) * | 2001-06-12 | 2002-12-19 | Smartrix Technologies Inc. | Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same |
US8071133B2 (en) | 2001-08-20 | 2011-12-06 | Stiefel Laboratories, Inc. | Oral dosage forms of water insoluble drugs and methods of making the same |
MY138657A (en) | 2001-12-21 | 2009-07-31 | Tibotec Pharm Ltd | broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
MY142238A (en) | 2002-03-12 | 2010-11-15 | Tibotec Pharm Ltd | Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
WO2003097616A1 (en) | 2002-05-17 | 2003-11-27 | Tibotec Pharmaceuticals Ltd | Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |
AU2003262574B2 (en) | 2002-08-14 | 2009-07-09 | Tibotec Pharmaceuticals Ltd. | Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors |
KR100557680B1 (ko) * | 2002-11-23 | 2006-03-07 | 한국유나이티드제약 주식회사 | 이트라코나졸의 용해도 개선을 위한 펠렛제제 및 그제조방법 |
DK1438960T4 (da) * | 2003-01-14 | 2013-03-25 | Cimex Pharma Ag | Sammensætning af itraconazol dispergeret i en hydrofil polymer med forhøjet biotilgængelighed |
DE60312636T3 (de) * | 2003-01-14 | 2014-12-24 | Acino Pharma Ag | Bioaequivalente Zusammensetzung in der Form einer festen Dispersion enthaltend Itraconazol und ein hydrophiles Polymer |
CN1845725A (zh) * | 2003-08-06 | 2006-10-11 | 尼马尔·穆利耶 | 包含水溶性药物的药物组合物 |
NZ544980A (en) | 2003-09-11 | 2009-02-28 | Tibotec Pharm Ltd | Entry inhibitors of the HIV virus |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
AR048650A1 (es) | 2004-05-04 | 2006-05-10 | Tibotec Pharm Ltd | Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih |
US7378441B2 (en) | 2004-05-07 | 2008-05-27 | Sequoia Pharmaceuticals, Inc. | Resistance-repellent retroviral protease inhibitors |
TW200613307A (en) | 2004-05-17 | 2006-05-01 | Tibotec Pharm Ltd | 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones |
AR049340A1 (es) | 2004-05-17 | 2006-07-19 | Tibotec Pharm Ltd | 1- heterociclil - l, 5- dihidro- pirido (3,2-b) indol - 2- onas |
ES2351702T3 (es) | 2004-05-17 | 2011-02-09 | Tibotec Pharmaceuticals | 1-fenil-1,5-dihidro-pirido[3,2-b]indol-2-onas 6,7,8,9-sustituidas útiles como agentes farmacéuticos antiinfecciosos. |
RU2008143342A (ru) | 2006-04-03 | 2010-05-10 | Тиботек Фармасьютикалз Лтд. (Ie) | 3, 4-дигидроимидазо(4, 5-b)пиридин-5-оны, ингибирующие вич(hiv) |
WO2008062440A2 (en) * | 2006-09-04 | 2008-05-29 | Panacea Biotec Limited | Programmable buoyant delivery technology |
KR100809903B1 (ko) * | 2006-09-05 | 2008-03-06 | 주식회사유한양행 | 안정화된 클로피도그렐-함유 입자, 그의 제조방법, 및 이를포함하는 약학 조성물 |
CN101283984B (zh) * | 2007-04-12 | 2010-05-26 | 永胜药品工业股份有限公司 | 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物 |
JP2008280254A (ja) * | 2007-05-08 | 2008-11-20 | Everest Pharm Industrial Co Ltd | 生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物 |
US8313527B2 (en) | 2007-11-05 | 2012-11-20 | Allergan, Inc. | Soft prosthesis shell texturing method |
AU2008329677B2 (en) | 2007-11-28 | 2015-02-19 | Sequoia Pharmaceuticals, Inc. | Compositions and methods for inhibiting cytochrome P450 2D6 |
CA2716348C (en) | 2008-02-21 | 2017-04-04 | Sequoia Pharmaceuticals, Inc. | Diamide inhibitors of cytochrome p450 |
US9050184B2 (en) | 2008-08-13 | 2015-06-09 | Allergan, Inc. | Dual plane breast implant |
US8877822B2 (en) | 2010-09-28 | 2014-11-04 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
US9205577B2 (en) | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
SG174658A1 (en) | 2010-04-01 | 2011-10-28 | Theravida Inc | Pharmaceutical formulations for the treatment of overactive bladder |
ES2623475T3 (es) * | 2010-05-11 | 2017-07-11 | Allergan, Inc. | Composiciones de porógenos, métodos para hacerlas y usos |
US11202853B2 (en) | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US8679279B2 (en) | 2010-11-16 | 2014-03-25 | Allergan, Inc. | Methods for creating foam-like texture |
CN102100678B (zh) * | 2011-02-18 | 2012-10-17 | 天津力生制药股份有限公司 | 伊曲康唑硫酸盐微丸及其制备方法 |
AU2013359158B2 (en) | 2012-12-13 | 2018-08-02 | Allergan, Inc. | Device and method for making a variable surface breast implant |
US10092392B2 (en) | 2014-05-16 | 2018-10-09 | Allergan, Inc. | Textured breast implant and methods of making same |
JP6841834B2 (ja) | 2016-01-20 | 2021-03-10 | テラヴィダ, インコーポレイテッドTheraVida, Inc. | 多汗症の処置のための方法および組成物 |
AU2019255599B2 (en) * | 2018-04-16 | 2024-02-29 | Bristol-Myers Squibb Holdings Ireland Unlimited Company | Apixaban formulations |
CN114767636B (zh) * | 2022-04-11 | 2023-11-07 | 苏州中化药品工业有限公司 | 伊曲康唑微丸、制备方法及伊曲康唑微丸胶囊 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005263A1 (en) * | 1992-09-03 | 1994-03-17 | Janssen Pharmaceutica N.V. | Beads having a core coated with an antifungal and a polymer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3346123A1 (de) * | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
GB8506792D0 (en) * | 1985-03-15 | 1985-04-17 | Janssen Pharmaceutica Nv | Derivatives of y-cyclodextrin |
CN1228693A (zh) * | 1996-06-28 | 1999-09-15 | 先灵公司 | 含有三唑类抗真菌化合物的口服组合物 |
-
1998
- 1998-03-18 AT AT98919155T patent/ATE241969T1/de active
- 1998-03-18 UA UA99042468A patent/UA60318C2/uk unknown
- 1998-03-18 SK SK544-99A patent/SK284813B6/sk not_active IP Right Cessation
- 1998-03-18 CZ CZ19991398A patent/CZ295502B6/cs not_active IP Right Cessation
- 1998-03-18 ES ES98919155T patent/ES2201485T3/es not_active Expired - Lifetime
- 1998-03-18 AU AU72107/98A patent/AU734248B2/en not_active Expired
- 1998-03-18 ID IDW990316A patent/ID21477A/id unknown
- 1998-03-18 CA CA002269501A patent/CA2269501C/en not_active Expired - Lifetime
- 1998-03-18 JP JP54490198A patent/JP3608800B2/ja not_active Expired - Lifetime
- 1998-03-18 KR KR10-1999-7003848A patent/KR100520936B1/ko not_active IP Right Cessation
- 1998-03-18 BR BR9806174-7A patent/BR9806174A/pt not_active Application Discontinuation
- 1998-03-18 EE EEP199900453A patent/EE03904B1/xx unknown
- 1998-03-18 HU HU0002056A patent/HU224217B1/hu active IP Right Grant
- 1998-03-18 CN CNB988020181A patent/CN1206984C/zh not_active Expired - Lifetime
- 1998-03-18 WO PCT/EP1998/001773 patent/WO1998042318A1/en active IP Right Grant
- 1998-03-18 IL IL12957598A patent/IL129575A/en not_active IP Right Cessation
- 1998-03-18 PL PL98335542A patent/PL190566B1/pl unknown
- 1998-03-18 AP APAP/P/1999/001516A patent/AP1227A/en active
- 1998-03-18 SI SI9830489T patent/SI0969821T1/xx unknown
- 1998-03-18 DE DE69815316T patent/DE69815316T2/de not_active Expired - Lifetime
- 1998-03-18 DK DK98919155T patent/DK0969821T3/da active
- 1998-03-18 NZ NZ335364A patent/NZ335364A/xx not_active IP Right Cessation
- 1998-03-18 PT PT98919155T patent/PT969821E/pt unknown
- 1998-03-18 RU RU99112123/15A patent/RU2218153C2/ru active
- 1998-03-18 EP EP98919155A patent/EP0969821B1/en not_active Expired - Lifetime
- 1998-03-18 TR TR1999/00990T patent/TR199900990T2/xx unknown
-
1999
- 1999-04-23 BG BG103356A patent/BG64434B1/bg unknown
- 1999-04-30 NO NO19992114A patent/NO325102B1/no not_active IP Right Cessation
- 1999-09-24 OA OA9900215A patent/OA11162A/en unknown
-
2000
- 2000-03-29 HK HK00101919A patent/HK1022840A1/xx not_active IP Right Cessation
-
2003
- 2003-11-04 CY CY0300079A patent/CY2384B1/xx unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005263A1 (en) * | 1992-09-03 | 1994-03-17 | Janssen Pharmaceutica N.V. | Beads having a core coated with an antifungal and a polymer |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100520936B1 (ko) | 항진균제 및 중합체로 코팅된 코어를 갖는 펠릿제 | |
KR100549095B1 (ko) | 항진균제 및 중합체로 코팅된 코어를 갖는 펠릿 | |
AP444A (en) | Beads having a core coated with an antifungal and a polymer. | |
KR20010041460A (ko) | 지질 저하제 및 중합체로 피복된 핵을 갖는 펠릿 | |
EP4096643A1 (en) | Controlled release selexipag composition | |
MXPA99004411A (en) | Pellets having a core coated with an antifungal and a polymer | |
MXPA00008322A (en) | Pellets having a core coated with an antifungal and a polymer | |
MXPA00010649A (en) | Pellets having a core coated with a lipid lowering agent and a polymer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120924 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20130924 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140923 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150918 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20160921 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170919 Year of fee payment: 13 |
|
EXPY | Expiration of term |